Are sugar-free electrolytes better for GLP-1 users
Results: Ninety one percent of participants meeting the Phase I inclusion criteria produced substantial TMAO quantities from L-carnitine
Even though it is often searched as "lipo c peptide," Lipo-C is not a peptide
These findings align with those of prior studies 58,59 , who found that LS reduced the detrimental structural and functional effects in rats exposed to cisplatin-induced nephrotoxicity, aluminum chloride -induced nephrotoxicity and dexamethasone-induced nephrotoxicity, respectively
This soluble fiber is well-tolerated by many patients and can be easily incorporated into the reduced food intake common during tirzepatide therapy
Cardiovascular and Kidney Outcomes No dedicated prospective RCT has yet been powered to compare combined SGLT2i and GLP-1RA therapy versus monotherapy for cardiovascular and kidney endpoints, although the ongoing PRECIDENTD trial is expected to address this gap [36]